CD38 and Miyoshi myopathy: DARA treatment reduced CD19+C24+CD38+ Bregs in MM patients and in vitro generated MDSCs (CD11b+CD14−HLA-DR−CD33+CD15+CD38+) causing a modification of the antitumor response (57).